Introduction: The latest revised version of the World Health Organization's dengue classification was released in 2009. A handful of studies have taken initiatives to evaluate the old and revised guidelines to determine early signs and symptoms of severe dengue. This retrospective study aimed to compare the classification of dengue using both the 1997 and 2009 guidelines in a selected cohort of dengue patients from Peninsular Malaysia between 2008 and 2012. Methodology: Adult dengue patients were recruited from tertiary hospitals in two different states, Selangor and Kelantan, in Peninsular Malaysia. Their clinical manifestations were assessed. Results: A total of 281 confirmed dengue patients were enrolled; the mean duration of illness at admission was five days. Of these, 88.6%, 10.7%, and 0.7% were classified according to the 1997 guidelines as having dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS), respectively. When the WHO 2009 guidelines were applied, 17.1%, 78.3%, and 4.6% were classified as dengue without warning signs, dengue with warning signs, and severe dengue, respectively. Conclusions: Our data suggests that the revised WHO 2009 guidelines stratify a much larger proportion of patients into a category that requires a higher level of medical and nursing care.
Introduction
Dengue is the most prevalent mosquito-borne viral disease affecting people in the tropic and sub-tropic regions of the world, caused by the infection of dengue virus (DENV). The virus exists as four related but antigenically distinct serotypes, namely DENV 1-4. These viruses are transmitted to humans via infected mosquitoes, namely Aedes sp. Individuals infected with any DENV serotype may remain asymptomatic or may present with symptoms ranging from mild febrile illness to severe and occasionally fatal hemorrhagic disease.
Globally, dengue fever and severe dengue cases have risen from less than 1,000 cases in 1955 to almost 1,000,000 cases in 2007. The number of countries reporting dengue cases has also increased to more than 60 countries [1] . Recently, Bhatt et al. [2] estimated an alarming 390 million dengue infection worldwide per year, which is three times higher than predicted by the World Health Organization (WHO). In Malaysia, the number of reported dengue cases has also shown an upward trend, with around 6,500 cases in 1995 to 32,767 cases in 2002 and more than 49,000 cases in 2007 [3] . All four DENV serotypes have been co-circulating in Malaysia [4] .
Under the earlier WHO classification [5] , patients infected with dengue were either classified as having dengue fever (DF) or dengue hemorrhagic fever (DHF) ( Table 1) . DHF patients were further stratified into four categories depending on severity, namely DHF-I, II, III, and IV. DHF-III and IV are defined as dengue shock syndrome (DSS) when patients manifest signs of circulatory failure. However, there were problems with this classification, as at times it proved difficult to apply in the clinical context. Furthermore, there were patients with severe dengue manifestations that did not fulfil the criteria of DHF [6, 7] . This was also seen in Malaysia [8, 9] . Thus, this classification underwent a proposed revision by the WHO in 2009, when the DHF criteria was revised and replaced with dengue with or without warning signs and severe dengue (Table 1) . Several reports have evaluated the differences between the two classification schemes. A study conducted in 18 countries, of which Malaysia was one, showed that a higher percentage of dengue cases could not be classified when the WHO 1997 classification was applied, as compared to the revised classification [10] . Similarly, all the fatal cases during a five-year study in Singapore fulfilled the severe dengue criteria using the WHO 2009 classification, but only 36% fulfilled the same criteria using the WHO 1997 classification [11] . On the other hand, another study indicated that both definitions are sensitive, but the diagnosis of dengue becomes more challenging in elderly patients [12] , suggesting that there are still limitations to both guidelines. Hence, a conclusion could not be drawn about its applicability.
Therefore, this study aimed to evaluate both classifications in identifying severe dengue cases in Malaysia.
Methodology

Ethics approval
The study was approved by the research and ethics committees of Universiti Sains Malaysia 
Sample collection
Four hundred and thirty-nine hospitalized suspected adult dengue patients, 13 years of age or older were recruited from three different hospitals, namely Hospital Universiti Sains Malaysia (HUSM), Hospital Raja Perempuan Zainab II (HKB), and Hospital Sungai Buloh (HSB). Among these, 185 confirmed dengue patients were from HUSM and HKB and were recruited between 2008 and 2010. Both hospitals are located in the state of Kelantan. Another 96 patients were confirmed dengue patients from HSB (recruited between 2010 and 2012), located in the state of Selangor. Blood samples were collected on the first day of admission, and the clinical data were retrieved from standardized case report forms after the patients were discharged. Laboratory confirmation, namely an IgM serological test, was carried out at the respective hospitals. These tests were independently repeated at least twice to confirm the results in addition to IgG serological tests. Dengue-specific IgG and IgM enzyme-linked immunosorbent assay (ELISA) kits (PanBio Diagnostics, Brisbane, Australia) were used in our laboratory. Diagnosis of dengue was determined by the expert clinicians at each study centre, respectively, based on the WHO criteria [1, 5] .
Inclusion and exclusion criteria
Informed consent was collected from all recruited patients upon hospitalization. Clinically diagnosed patients with positive serological test either for IgG, IgM, or both were included in this study. Patients who had been co-infected with other pathogens, or were negative for both IgG and IgM, were excluded.
WHO classifications [1, 5] Table 1 shows the previous and recent WHO classifications for dengue severity [1, 5] . According to the Malaysian Ministry of Health [3] , the increase of hematocrit (Hct) was defined as more than 46% and 40% for males and females, respectively. This is based on the local normal range of Hct in adults and is due to the unavailability of baseline Hct levels in the respective study centers.
Statistical analysis
Chi-square was used to evaluate statistical differences in categorical variables between groups. The Statistical Package for Social Sciences (SPSS) version 20 (SPSS Inc., Chicago, IL, USA) was used for data analyses.
Results
Among 439 patients, 281 (64%) dengue subjects were confirmed via serological tests (IgM and/or IgG). The excluded subjects were either negative for the serological tests, diagnosed to have co-infection during admission, or their clinical data were unavailable. Table 2 shows the demographic data of the recruited subjects. Males comprised 60% of the subjects (p = 0.001), and more than 80% of the subjects were under 50 years of age. A summary of clinical data presentation with prevalence is shown in Table 3 . When patients were classified according to the WHO 1997 guidelines, DF was found most frequently (88.6% of the cases), followed by DHF (10.7%) and DSS (0.7%) (Figure 1) . The trend shifted when they were classified based on the WHO 2009 guidelines, whereby the majority of the patients were classified as dengue with warning signs (DW) (78.29%) (Figure 2 ).
In the 1997 classification, DSS was considered the severest form of dengue. Patients who were classified in this category expressed bleeding manifestations, thrombocytopenia, and pleural effusion and/or ascites. However, in the 2009 classification, only 67% of patients with severe dengue (SD) had bleeding manifestations, 95% had thrombocytopenia, and only 57 % had pleural effusion and /or ascites. Bleeding manifestations were included either by patients reporting or by detection of bleeding during their hospitalization. Pleural effusion and ascites were clinical findings made by the managing physician.
As shown in Table 4 , 197 (70%) of the patients classified as DF by WHO 1997 were classified as DW, 48 (17%) as dengue without warning signs (D), and around 4 (1%) as SD when grouped by WHO 2009. Not all patients grouped under SD by WHO 2009 were classified as DSS by WHO 1997; in fact, about 1.6% of the DF patients (under WHO 1997 guidelines) were classified as SD. These were patients who had only hematemesis or increased AST as signs of severity and were not sufficient to be classified as DHF or DSS (Table 4 ). The percentage values in the total rows and columns are equivalent to Figures 1 and 2 . Percentages are calculated based on the total number of patients.
Discussion
Several studies [10, 13, 14] reported that the revised WHO classification is more sensitive as well as more or comparably specific in identifying severe cases. In contrast, some still indicate that WHO 1997 is more sensitive -though less specific -in capturing severe cases [15] .
We performed a retrospective observational study of dengue, which included 281 confirmed adult dengue patients (male: female ratio 1.5:1, range of age 13-88 years) admitted to the HUSM and HKB (between 2008 and 2010) as well as HSB (between 2010 and 2012).
We noted that the application of the two guidelines yielded different results. When classified according to WHO 1997 guidelines, our study cohort showed the highest percentage of DF, followed by DHF and DSS. This is in agreement with earlier reports [14, 16, 17] . However, the trend was different when the revised guidelines were used to classify the subjects. The highest percentage of cases were found to be DW, followed by D and SD. This finding was in line with that of Barniol et al. [10] , whose study population included Malaysia. Although there are studies utilizing the 2009 guidelines [14, 16] , their findings are not similar to each other and are different from those of this study as well.
Our results show that DW was the most common classification (78.3%), followed by D (17.1%) and SD (4.6%). Narvaez et al. [14] found rates of both DW and SD to be similar and high in percentage (48% and 44%, respectively). Gan et al. [16] found D to be the most frequently occurring classification (48%), followed by DW (36%) and SD (16%). These differences could be due to a very large number of samples [16] and the use of a pediatric cohort [14] .
In the current study, WHO 2009 captured higher cases of SD than those captured as DSS by WHO 1997. Some of these discrepancies were explained by patients who had increased AST or ALT > 1000U/L. This deranged liver function has also been seen during dengue infection in many populations [18] [19] [20] . However, these patients had been classified as DF or DHF under the 1997 guidelines.
The low percentage of DHF in comparison to DW is expected, as DHF requires the patients to meet all four criteria. DW has looser categories, which allows us to capture more patients potentially at risk of developing severe manifestations. This may eventually prompt clinicians to treat patients aggressively before they progress into SD. Our high percentage of hospitalized patients classified as DW is in line with the recommendation of the WHO 2009 guidelines that patients with warning signs are to be referred for inpatient management. However, this may increase the burden on the health care system. Several limitations were encountered in this study. First, dengue infection was only confirmed by clinical diagnosis followed by dengue-specific IgG and IgM serological tests, as these are the routine practice in the hospitals where the sampling was done. However, these tests were independently repeated at least twice to confirm the results. Diagnosis based on a single laboratory confirmation through dengue-specific IgM serological tests have also been applied elsewhere [21, 22] . Second, different clinicians may classify any clinical manifestations of dengue fever differently. Third, to avoid any potential sampling biases, we did a similar analysis separately on the two cohorts (the 2008-2010 cohort versus the 2010-2012 cohort) and found no significant different between them (data not shown). Therefore, we believe that the impact of such limitations is minimal.
Conclusions
To the best of our knowledge, we have provided a platform of pros and cons for both new and old dengue classifications with the data from a Malaysian cohort. The revised 2009 WHO classification stratifies a much larger proportion of patients into a category that requires a higher level of medical and nursing care. This would have a significant impact on hospital resources in the region and would require a heightened level of awareness among health care personnel about the dangers of dengue.
